{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:17Z","timestamp":1707524657821},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,26]]},"DOI":"10.7759\/cureus.25371","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T23:36:16Z","timestamp":1653608176000},"source":"Crossref","is-referenced-by-count":0,"title":["Leukocytoclastic Vasculitis of the Foot and Ankle: A Case Report With Over Five-Year Follow-Up"],"prefix":"10.7759","author":[{"given":"Ramez","family":"Sakkab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry M","family":"Fabrikant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.04.015","article-title":"Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota","volume":"89","author":"Arora A","year":"2014","unstructured":"Arora A, Wetter DA, Gonzalez-Santiago TM, et al.. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2014, 89:1515-24. 10.1016\/j.mayocp.2014.04.015","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02688-x","article-title":"Diagnosis and management of leukocytoclastic vasculitis","volume":"16","author":"Fraticelli P","year":"2021","unstructured":"Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021, 16:831-41. 10.1007\/s11739-021-02688-x","journal-title":"Intern Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004238","article-title":"Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: a retrospective study in 112 patients","volume":"95","author":"Bouiller K","year":"2016","unstructured":"Bouiller K, Audia S, Devilliers H, et al.. Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: a retrospective study in 112 patients. Medicine (Baltimore). 2016, 95:e4238. 10.1097\/MD.0000000000004238","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"70","author":"Sunderk\u00f6tter CH","year":"2018","unstructured":"Sunderk\u00f6tter CH, Zelger B, Chen KR, et al.. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 2018, 70:171-84. 10.1002\/art.40375","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/09546630500277971","article-title":"Management of leukocytoclastic vasculitis","volume":"16","author":"Sunderk\u00f6tter C","year":"2005","unstructured":"Sunderk\u00f6tter C, Bonsmann G, Sindrilaru A, et al.. Management of leukocytoclastic vasculitis. J Dermatolog Treat. 2005, 16:193-206. 10.1080\/09546630500277971","journal-title":"J Dermatolog Treat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.3816","article-title":"Costs and consequences associated with misdiagnosed lower extremity cellulitis","volume":"153","author":"Weng QY","year":"2017","unstructured":"Weng QY, Raff AB, Cohen JM, et al.. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017, 153:141-6. 10.1001\/jamadermatol.2016.3816","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.15921","article-title":"Cellulitis: commonly misdiagnosed or just misunderstood?","volume":"317","author":"Moran GJ","year":"2017","unstructured":"Moran GJ, Talan DA. Cellulitis: commonly misdiagnosed or just misunderstood?. JAMA. 2017, 317:760-1. 10.1001\/jama.2016.15921","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330803","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods","volume":"33","author":"Bloch DA","year":"1990","unstructured":"Bloch DA, Michel BA, Hunder GG, et al.. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum. 1990, 33:1068-73. 10.1002\/art.1780330803","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2020.06.015","article-title":"Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment","volume":"38","author":"Guzman AK","year":"2020","unstructured":"Guzman AK, Balagula Y. Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment. Clin Dermatol. 2020, 38:613-28. 10.1016\/j.clindermatol.2020.06.015","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors","volume":"87","author":"Sokumbi O","year":"2012","unstructured":"Sokumbi O, Wetter DA, Makol A, et al.. Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors. Mayo Clin Proc. 2012, 87:739-45. 10.1016\/j.mayocp.2012.04.011","journal-title":"Mayo Clin Proc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17462","article-title":"Leukocytoclastic vasculitis: depiction of the diagnostic dilemma","volume":"13","author":"Bhesania S","year":"2021","unstructured":"Bhesania S, Raol K, Medina C, et al.. Leukocytoclastic vasculitis: depiction of the diagnostic dilemma. Cureus. 2021, 13:e17462. 10.7759\/cureus.17462","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9932425","article-title":"The many faces of purpura: vancomycin-induced leukocytoclastic vasculitis","volume":"2021","author":"Zadroga JA","year":"2021","unstructured":"Zadroga JA, Mogulla V, Grant C, et al.. The many faces of purpura: vancomycin-induced leukocytoclastic vasculitis. Case Rep Infect Dis. 2021, 2021:9932425. 10.1155\/2021\/9932425","journal-title":"Case Rep Infect Dis"},{"key":"ref13","article-title":"Leukocytoclastic vasculitis due to etanercept","volume":"27","author":"Galaria NA","year":"2000","unstructured":"Galaria NA, Werth VP, Schumacher HR. Leukocytoclastic vasculitis due to etanercept. J Rheum. 2000, 27:2041-4.","journal-title":"J Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7912","article-title":"Leukocytoclastic vasculitis: an early skin biopsy makes a difference","volume":"12","author":"Azanza JJC","year":"2020","unstructured":"Azanza JJC, Sarmiento PMC, Lia NL, et al.. Leukocytoclastic vasculitis: an early skin biopsy makes a difference. Cureus. 2020, 12:e7912. 10.7759\/cureus.7912","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650400066014","article-title":"Cutaneous leukocytoclastic vasculitis: clinical and laboratory features of 82 patients seen in private practice","volume":"120","author":"af Ekenstam E","year":"1984","unstructured":"af Ekenstam E, Callen JP. Cutaneous leukocytoclastic vasculitis: clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984, 120:484-9. 10.1001\/archderm.1984.01650400066014","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ MD.0000000000000009.","article-title":"The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features","volume":"92","author":"Loricera J","year":"2013","unstructured":"Loricera J, Calvo-R\u00edo V, Ortiz-Sanju\u00e1n F, et al..  The spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features. Medicine (Baltimore). 2013, 92:331-43. 10.1097\/ MD.0000000000000009.","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000051611","article-title":"Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy","volume":"202","author":"Hunger RE","year":"2001","unstructured":"Hunger RE, D\u00fcrr C, Brand CU. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy. Dermatology. 2001, 202:123-6. 10.1159\/000051611","journal-title":"Dermatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390%2Fjcm11030739","article-title":"Clinical manifestations of leukocytoclastic vasculitis, treatment, and outcome in patients with ulcerative colitis: a systematic review of the literature","volume":"11","author":"Pantic I","year":"2022","unstructured":"Pantic I, Jevtic D, Nordstrom C, et al.. Clinical manifestations of leukocytoclastic vasculitis, treatment, and outcome in patients with ulcerative colitis: a systematic review of the literature. J Clin Med. 2022, 11:739. 10.3390%2Fjcm11030739","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2006.00239.x","article-title":"Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis","volume":"47","author":"Tai YJ","year":"2006","unstructured":"Tai YJ, Chong AH, Williams RA, et al.. Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis. Australasian J Dermatol. 2006, 47:92-6. 10.1111\/j.1440-0960.2006.00239.x","journal-title":"Australasian J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0213-x","article-title":"Pyoderma gangrenosum","volume":"6","author":"Maverakis E","year":"2020","unstructured":"Maverakis E, Marzano AV, Le ST, et al.. Pyoderma gangrenosum. Nat Rev Dis Primers. 2020, 6:81. 10.1038\/s41572-020-0213-x","journal-title":"Nat Rev Dis Primers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95410-leukocytoclastic-vasculitis-of-the-foot-and-ankle-a-case-report-with-over-five-year-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:01Z","timestamp":1707507361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95410-leukocytoclastic-vasculitis-of-the-foot-and-ankle-a-case-report-with-over-five-year-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.25371","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}